Murine embryonic stem cells secrete cytokines/growth modulators that enhance cell survival/anti-apoptosis and stimulate colony formation of murine hematopoietic progenitor cells

被引:53
作者
Guo, Ying
Graham-Evans, Barbara
Broxmeyer, Hal E.
机构
[1] Indiana Univ, Sch Med, Walther Oncol Ctr, Dept Microbiol Immunol, Indianapolis, IN 46202 USA
[2] Walther Canc Inst, Indianapolis, IN USA
关键词
embryonic stem cells; survival; apoptosis; cytokines/chemokines; hematopoietic progenitors;
D O I
10.1634/stemcells.2005-0457
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Stromal cell-derived factor (SDF)-1/CXCL12, released by murine embryonic stem (ES) cells, enhances survival, chemotaxis, and hernatopoietic differentiation of murine ES cells. Conditioned medium (CM) from murine ES cells growing in the presence of leukemia inhibitory factor (LIF) was generated while the ES cells were in an undifferentiated Oct-4 expressing state. ES cell-CM enhanced survival of normal murine bone marrow myelloid progenitors (CFU-GM) subjected to delayed growth factor addition in vitro and decreased apoptosis of murine bone marrow c-kit(+)lin- cells. ES CM contained interleukin (IL)-1 alpha, IL-10, IL-11, macrophage-colony stimulating factor (CSF), oncostatin M, stem cell factor, vascular endothelial growth factor, as well as a number of chemokines and other proteins, some of which are known to enhance survival/antiapoptosis of progenitors. Irradiation of ES cells enhanced release of some proteins and decreased release of others. IL-6, FGF-9, and TNF-alpha, not detected prior to irradiation was found after ES cells were irradiated. ES cell CM also stimulated CFU-GM colony formation. Thus, undifferentiated murine ES cells growing in the presence of LIF produce/release a number of biologically active interleukins, CSFs, chemokines, and other growth modulatory proteins, results which may be of physiological and/or practical significance.
引用
收藏
页码:850 / 856
页数:7
相关论文
共 15 条
[1]   Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo [J].
Broxmeyer, HE ;
Cooper, S ;
Kohli, L ;
Hangoc, G ;
Lee, Y ;
Mantel, C ;
Clapp, DW ;
Kim, CH .
JOURNAL OF IMMUNOLOGY, 2003, 170 (01) :421-429
[2]  
DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27
[3]  
Gardner RL, 1997, INT J DEV BIOL, V41, P235
[4]  
Guo Y, 2006, STEM CELLS, V24, P211, DOI 10.1634/stemcells.2005-0085
[5]  
Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085
[6]   IN-VITRO DIFFERENTIATION OF EMBRYONIC STEM-CELLS [J].
KELLER, GM .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (06) :862-869
[7]   Introducing embryonic stem cells [J].
Nichols, J .
CURRENT BIOLOGY, 2001, 11 (13) :R503-R505
[8]   Multilineage differentiation from human embryonic stem cell lines [J].
Odorico, JS ;
Kaufman, DS ;
Thomson, JA .
STEM CELLS, 2001, 19 (03) :193-204
[9]   Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2 [J].
Reid, S ;
Ritchie, A ;
Boring, L ;
Gosling, J ;
Cooper, S ;
Hangoc, G ;
Charo, IF ;
Broxmeyer, HE .
BLOOD, 1999, 93 (05) :1524-1533
[10]   Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells [J].
Robbins, PB ;
Yu, XJ ;
Skelton, DM ;
Pepper, KA ;
Wasserman, RM ;
Zhu, L ;
Kohn, DB .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9466-9474